Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
2
×
ipo
2
×
life sciences
national blog main
national top stories
san francisco
san francisco blog main
san francisco top stories
third rock ventures
2
×
warp drive bio
acetylon pharmaceuticals
ambys medicines
amgen
cancer
cancer drugs
cell therapy
clinical trials
cobimetinib
constellation pharmaceuticals
gene therapy
genentech
holger willenbring
investing
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
revolution medicines
roche
salk institute for biological studies
san diego blog main
What
medicines
2
×
aiming
ambys
big
biotech
cancer
control
deadly
deal
debuted
despite
diseases
drug
family
formed
future
hardest
hit
hottest
hunters
ipo
launch
liver
make
new
proteins
ras
reels
research
revolution
startup
takeda
targets
today
treatments
unusual
variety
Language
unset
Current search:
medicines
×
ipo
×
" third rock ventures "
×
deals
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
